Resultados da busca - Claudio Cerchione

Refinar Resultados
  1. 1
    Bispecific antibodies for the treatment of relapsed/refractory multiple myeloma: updates and future perspectives

    Bispecific antibodies for the treatment of relapsed/refractory multiple myeloma: updates and future perspectives por Ricardo Parrondo, Sikander Ailawadhi, Claudio Cerchione

    Publicado em 2024
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  2. 2
    An overview of prognostic markers in patients with CLL

    An overview of prognostic markers in patients with CLL por Julie Braish, Claudio Cerchione, Alessandra Ferrajoli

    Publicado em 2024
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  3. 3
    A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target

    A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target por Andrea Ghelli Luserna di Rorà, Claudio Cerchione, Giovanni Martinelli, Giorgia Simonetti

    Publicado em 2020
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  4. 4
    A Review of Clinical Outcomes of CAR T-Cell Therapies for B-Acute Lymphoblastic Leukemia

    A Review of Clinical Outcomes of CAR T-Cell Therapies for B-Acute Lymphoblastic Leukemia por Massimo Martino, Caterina Alati, Filippo Antonio Canale, Gerardo Musuraca, Giovanni Martinelli, Claudio Cerchione

    Publicado em 2021
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  5. 5
    Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging Treatments

    Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging Treatments por Massimo Offidani, Laura Corvatta, Sonia Morè, Davide Nappi, Giovanni Martinelli, Attilio Olivieri, Claudio Cerchione

    Publicado em 2021
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  6. 6
    Anemia in patients receiving anticancer treatments: focus on novel therapeutic approaches

    Anemia in patients receiving anticancer treatments: focus on novel therapeutic approaches por Claudia Bozzini, Fabiana Busti, Giacomo Marchi, Alice Vianello, Claudio Cerchione, Giovanni Martinelli, Domenico Girelli

    Publicado em 2024
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  7. 7
    CAR-T cell therapy: a potential new strategy against prostate cancer

    CAR-T cell therapy: a potential new strategy against prostate cancer por Giuseppe Schepisi, Maria Concetta Cursano, Chiara Casadei, Cecilia Menna, Amelia Altavilla, Cristian Lolli, Claudio Cerchione, Giovanni Paganelli, Daniele Santini, Giuseppe Tonini, Giovanni Martinelli, Ugo De Giorgi

    Publicado em 2019
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  8. 8
    IDH1/IDH2 Inhibition in Acute Myeloid Leukemia

    IDH1/IDH2 Inhibition in Acute Myeloid Leukemia por Claudio Cerchione, Alessandra Romano, Naval Daver, Courtney D. DiNardo, Elias Jabbour, Marina Konopleva, Farhad Ravandi‐Kashani, Tapan M. Kadia, Maria Paola Martelli, Alessandro Isidori, Giovanni Martinelli, Hagop M. Kantarjian

    Publicado em 2021
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  9. 9
    T-Cell Receptor Repertoire Sequencing and Its Applications: Focus on Infectious Diseases and Cancer

    T-Cell Receptor Repertoire Sequencing and Its Applications: Focus on Infectious Diseases and Cancer por L. Mazzotti, Anna Gaimari, Sara Bravaccini, Roberta Maltoni, Claudio Cerchione, Manel Juan, Europa Azucena-Gonzalez Navarro, Anna Pasetto, Daniela Nascimento Silva, Valentina Ancarani, Vittorio Sambri, Luana Calabrò, Giovanni Martinelli, Massimiliano Mazza

    Publicado em 2022
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  10. 10
    Randomized comparison of power Doppler ultrasonography-guided core-needle biopsy with open surgical biopsy for the characterization of lymphadenopathies in patients with suspected lymphoma

    Randomized comparison of power Doppler ultrasonography-guided core-needle biopsy with open surgical biopsy for the characterization of lymphadenopathies in patients with suspected... por Novella Pugliese, Maria Di Perna, Immacolata Cozzolino, Giuseppe Ciancia, Guido Pettinato, Pio Zeppa, Valeria Varone, Stefania Masone, Claudio Cerchione, Roberta Della Pepa, Luigia Simeone, Claudia Giordano, Vincenzo Martinelli, Claudia Salvatore, Fabrizio Pane, Marco Picardi

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  11. 11
    Exploring the Relationship Between Humoral and Cellular T Cell Responses Against <scp>SARS</scp>‐<scp>CoV</scp>‐2 in Exposed Individuals From Emilia Romagna Region and <scp>COVID</scp>‐19 Severity

    Exploring the Relationship Between Humoral and Cellular T Cell Responses Against <scp>SARS</scp>‐<scp>CoV</scp>‐2 in Exposed Individuals From Emilia Romagna Region and <scp>COVID</... por L. Mazzotti, Patricia Borges de Souza, Irene Azzali, Davide Angeli, Oriana Nanni, Vittorio Sambri, Simona Semprini, Sara Bravaccini, Claudio Cerchione, Anna Gaimari, Fabio Nicolini, Valentina Ancarani, Giovanni Martinelli, Anna Pasetto, Hugo Calderón, Manel Juan, Massimiliano Mazza

    Publicado em 2025
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  12. 12
    Immunotherapy in Acute Myeloid Leukemia: Where We Stand

    Immunotherapy in Acute Myeloid Leukemia: Where We Stand por Alessandro Isidori, Claudio Cerchione, Naval Daver, Courtney D. DiNardo, Guillermo Garcia‐Manero, Marina Konopleva, Elias Jabbour, Farhad Ravandi, Tapan M. Kadia, Adolfo de la Fuente Burguera, Alessandra Romano, Federica Loscocco, Giuseppe Visani, Giovanni Martinelli, Hagop M. Kantarjian, Antonio Curti

    Publicado em 2021
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  13. 13
    P557: HEMATOLOGIC IMPROVEMENTS WITH IVOSIDENIB + AZACITIDINE COMPARED WITH PLACEBO + AZACITIDINE IN PATIENTS WITH NEWLY-DIAGNOSED ACUTE MYELOID LEUKEMIA

    P557: HEMATOLOGIC IMPROVEMENTS WITH IVOSIDENIB + AZACITIDINE COMPARED WITH PLACEBO + AZACITIDINE IN PATIENTS WITH NEWLY-DIAGNOSED ACUTE MYELOID LEUKEMIA por Hartmut Döhner, Pau Montesinos, Susana Vives Polo, Ewa Zarzycka, Jingjing Wang, Giambattista Bertani, Michael Heuser, R. Calado, Andre C. Schuh, S.-P. Yeh, Adolfo de la Fuente, Claudio Cerchione, S. Daigle, Jia-Jun Hui, S. Pandya, D. Gianolio, Christian Récher, Stéphane de Botton

    Publicado em 2022
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  14. 14
    Non-small cell lung cancer and the tumor microenvironment: making headway from targeted therapies to advanced immunotherapy

    Non-small cell lung cancer and the tumor microenvironment: making headway from targeted therapies to advanced immunotherapy por Anna De Lucia, L. Mazzotti, Anna Gaimari, Matteo Zurlo, Roberta Maltoni, Claudio Cerchione, Sara Bravaccini, Angelo Delmonte, Lucio Crinò, Patricia Borges de Souza, Luigi Pasini, Fabio Nicolini, F. Bianchi, Manel Juan, Hugo Calderón, C Magnoni, Luca Gazzola, Paola Ulivi, Massimiliano Mazza

    Publicado em 2025
    Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  15. 15
    Molecular Characterization of Clinical Response and Relapse in Patients with <i>IDH1</i>m ND-AML Treated with Ivo+AZA in the AGILE Study

    Molecular Characterization of Clinical Response and Relapse in Patients with <i>IDH1</i>m ND-AML Treated with Ivo+AZA in the AGILE Study por Hartmut Döhner, Dylan M. Marchione, Sung Choe, Pau Montesinos, Christian Récher, Susana Vives, Ewa Zarzycka, Jianxiang Wang, Claudio Cerchione, Michael Heuser, Rodrigo T. Calado, Andre C. Schuh, Su‐Peng Yeh, Adolfo de la Fuente, Jianan Hui, Prapti Patel, Diego A. Gianolio, Scott R. Daigle, Courtney D. DiNardo, Stéphane de Botton

    Publicado em 2022
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  16. 16
    Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN)

    Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN) por Evangelos Terpos, Pellegrino Musto, Monika Engelhardt, Michel Delforge, Gordon Cook, Francesca Gay, Niels W.C.J. van de Donk, Ioannis Ntanasis‐Stathopoulos, Annette Juul Vangsted, Christoph Driessen, Fredrik Schjesvold, Claudio Cerchione, Sonja Zweegman, Roman Hájek, Philippe Moreau, Hermann Einsele, Jesús F. San Miguel, Mario Boccadoro, Meletios Α. Dimopoulos, Pieter Sonneveld, Heinz Ludwig

    Publicado em 2023
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  17. 17
    A large-scale database of T-cell receptor beta (TCRβ) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.

    A large-scale database of T-cell receptor beta (TCRβ) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2. por Sean Nolan, Marissa Vignali, Mark Klinger, Jennifer N. Dines, Ian M. Kaplan, Emily Svejnoha, Tracy Craft, Katie Boland, Mitch Pesesky, Rachel Gittelman, Thomas M. Snyder, Christopher J. Gooley, Simona Semprini, Claudio Cerchione, Massimiliano Mazza, Ottavia M. Delmonte, Kerry Dobbs, Gonzalo Carreño‐Tarragona, Santiago Barrio, Vittorio Sambri, Giovanni Martinelli, Jason D. Goldman, James R. Heath, Luigi D. Notarangelo, Jonathan M. Carlson, Joaquín Martínez‐López, Harlan Robins

    Publicado em 2020
    Obter o texto integral
    Pré-impressão
    Salvar na lista
    Na minha lista:
  18. 18
    Alnuctamab (ALNUC; BMS-986349; CC-93269), a B-Cell Maturation Antigen (BCMA) x CD3 T-Cell Engager (TCE), in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Results from a Phase 1 First-in-Human Clinical Study

    Alnuctamab (ALNUC; BMS-986349; CC-93269), a B-Cell Maturation Antigen (BCMA) x CD3 T-Cell Engager (TCE), in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Results... por Sandy W. Wong, Noffar Bar, Laura París, Craig C. Hofmeister, Markus Hansson, Armando Santoro, María‐Victoria Mateos, Paula Rodríguez‐Otero, Johan Lund, Cristina Encinas, Andrew J. Yee, Albert Oriol, Claudio Cerchione, Javier de la Rubia, Barbara Ferstl, Kristina Carlson, Paz Ribas, Arancha Bermúdez, Isaac W. Boss, Allison Gaudy, Shaoyi Li, Kevin Hsu, Colin D. Godwin, Michael R. Burgess, Jesús F. San Miguel, Luciano J. Costa

    Publicado em 2022
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  19. 19
    A large-scale database of T-cell receptor beta sequences and binding associations from natural and synthetic exposure to SARS-CoV-2

    A large-scale database of T-cell receptor beta sequences and binding associations from natural and synthetic exposure to SARS-CoV-2 por Sean Nolan, Marissa Vignali, Mark Klinger, Jennifer N. Dines, Ian M. Kaplan, Emily Svejnoha, Tracy Craft, Katie Boland, Mitchell W. Pesesky, Rachel M. Gittelman, Thomas M. Snyder, Christopher J. Gooley, Simona Semprini, Claudio Cerchione, Fabio Nicolini, Massimiliano Mazza, Ottavia M. Delmonte, Kerry Dobbs, Gonzalo Carreño‐Tarragona, Santiago Barrio, Vittorio Sambri, Giovanni Martinelli, Jason D. Goldman, James R. Heath, Luigi D. Notarangelo, Joaquín Martínez‐López, Bryan Howie, Jonathan M. Carlson, Harlan Robins

    Publicado em 2025
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  20. 20
    Alnuctamab (ALNUC; BMS-986349; CC-93269), a 2+1 B-Cell Maturation Antigen (BCMA) × CD3 T-Cell Engager (TCE), Administered Subcutaneously (SC) in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results from a Phase 1 First-in-Human Clinical Study

    Alnuctamab (ALNUC; BMS-986349; CC-93269), a 2+1 B-Cell Maturation Antigen (BCMA) × CD3 T-Cell Engager (TCE), Administered Subcutaneously (SC) in Patients (Pts) with Relapsed/Refrac... por Noffar Bar, María‐Victoria Mateos, Paz Ribas, Markus Hansson, Laura París, Craig C. Hofmeister, Paula Rodríguez‐Otero, Maria Aranzazu Bermúdez, Thomas G Martin, Armando Santoro, Andrew J. Yee, Maria Creignou, Cristina Encinas Rodriguez, Claudio Cerchione, Javier de la Rubia, Albert Oriol, Heidi Waibel, Britta Besemer, Ethan Thompson, Brian F. Kiesel, Jinjie Chen, Alexander Yaw Fui Chung, Isaac W. Boss, Allison Gaudy, Shaoyi Li, Kevin Hsu, Colin D. Godwin, Michael R. Burgess, Jesús F. San Miguel, Luciano J. Costa

    Publicado em 2023
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:

Ferramentas de busca: